Form 8-K - Current report:
SEC Accession No. 0001193125-25-056674
Filing Date
2025-03-18
Accepted
2025-03-18 16:15:20
Documents
15
Period of Report
2025-03-13
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d835509d8k.htm   iXBRL 8-K 37990
2 EX-99.1 d835509dex991.htm EX-99.1 10112
6 GRAPHIC g835509g0318102252535.jpg GRAPHIC 3133
  Complete submission text file 0001193125-25-056674.txt   186543

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crgx-20250313.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20250313_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20250313_pre.xml EX-101.PRE 11702
17 EXTRACTED XBRL INSTANCE DOCUMENT d835509d8k_htm.xml XML 3771
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 25748525
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)